These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 31705718)

  • 1. Pharmacotherapy in relieving the symptoms of burning mouth syndrome: A 1-year follow-up study.
    Paudel D; Utsunomiya M; Yoshida K; Giri S; Uehara O; Matsuoka H; Chiba I; Toyofuku A; Abiko Y
    Oral Dis; 2020 Jan; 26(1):193-199. PubMed ID: 31705718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pain-relieving effects of clonazepam and amitriptyline in burning mouth syndrome: a retrospective study.
    Fenelon M; Quinque E; Arrive E; Catros S; Fricain JC
    Int J Oral Maxillofac Surg; 2017 Nov; 46(11):1505-1511. PubMed ID: 28473243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The dubious effect of milnacipran for the treatment of burning mouth syndrome.
    Sugimoto K
    Clin Neuropharmacol; 2011; 34(4):170-3. PubMed ID: 21738026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two cases of burning mouth syndrome treated with olanzapine.
    Ueda N; Kodama Y; Hori H; Umene W; Sugita A; Nakano H; Yoshimura R; Nakamura J
    Psychiatry Clin Neurosci; 2008 Jun; 62(3):359-61. PubMed ID: 18588600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Five Patients With Burning Mouth Syndrome in Whom an Antidepressant (Serotonin-Noradrenaline Reuptake Inhibitor) Was Not Effective, but Pregabalin Markedly Relieved Pain.
    Ito M; Tokura T; Yoshida K; Nagashima W; Kimura H; Umemura E; Tachibana M; Miyauchi T; Kobayashi Y; Arao M; Ozaki N; Kurita K
    Clin Neuropharmacol; 2015; 38(4):158-61. PubMed ID: 26166242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effective perospirone augmentation with clonazepam for treatment-resistant burning mouth syndrome: A case report.
    Watanabe M; Takao C; Maeda C; Nayanar G; Tominaga R; Kimura Y; Tu TTH; Nagamine T; Toyofuku A
    Neuropsychopharmacol Rep; 2024 Jun; 44(2):464-467. PubMed ID: 38500267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. QTc Shortening on Electrocardiogram With Amitriptyline May Indicate No Effect on Pain Relief in Burning Mouth Syndrome.
    Nagamine T; Watanabe T; Toyofuku A
    Clin Neuropharmacol; 2024 Mar-Apr 01; 47(2):33-36. PubMed ID: 38285063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Milnacipran dose-effect study in patients with burning mouth syndrome.
    Kato Y; Sato T; Katagiri A; Umezaki Y; Takenoshita M; Yoshikawa T; Sato Y; Toyofuku A
    Clin Neuropharmacol; 2011; 34(4):166-9. PubMed ID: 21738023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of milnacipran for the treatment of chronic pain in the orofacial region.
    Ito M; Kimura H; Yoshida K; Kimura Y; Ozaki N; Kurita K
    Clin Neuropharmacol; 2010; 33(2):79-83. PubMed ID: 20375656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Challenge in the diagnosis, evaluation, and management of burning mouth sensation: A retrospective cohort study.
    Wu S; Zhang W; Wang X; He C; Yan Z
    J Am Dent Assoc; 2023 May; 154(5):436-444. PubMed ID: 36167586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Burning mouth syndrome: a retrospective study investigating spontaneous remission and response to treatments.
    Sardella A; Lodi G; Demarosi F; Bez C; Cassano S; Carrassi A
    Oral Dis; 2006 Mar; 12(2):152-5. PubMed ID: 16476036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acupuncture and burning mouth syndrome: a pilot study.
    Sardella A; Lodi G; Tarozzi M; Varoni E; Franchini R; Carrassi A
    Pain Pract; 2013 Nov; 13(8):627-32. PubMed ID: 23336607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Burning mouth syndrome. A retrospective analysis of clinical characteristics and treatment outcomes.
    Pinto A; Sollecito TP; DeRossi SS
    N Y State Dent J; 2003 Mar; 69(3):18-24. PubMed ID: 12764983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical characteristics and management outcome in the burning mouth syndrome. An open study of 130 patients.
    Gorsky M; Silverman S; Chinn H
    Oral Surg Oral Med Oral Pathol; 1991 Aug; 72(2):192-5. PubMed ID: 1923398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analgesic effect of topical oral capsaicin gel in burning mouth syndrome.
    Jørgensen MR; Pedersen AM
    Acta Odontol Scand; 2017 Mar; 75(2):130-136. PubMed ID: 28007005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclosporine: a novel therapeutic approach for Burning Mouth Syndrome.
    Saraceno R; Lorè B; Pavlidis A; Karaiskou M; Arcuri C; Chimenti S; Magnato R
    G Ital Dermatol Venereol; 2016 Oct; 151(5):480-4. PubMed ID: 26091275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Burning mouth syndrome and burning mouth in hypothyroidism: proposal for a diagnostic and therapeutic protocol.
    Femiano F; Lanza A; Buonaiuto C; Gombos F; Nunziata M; Cuccurullo L; Cirillo N
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Jan; 105(1):e22-7. PubMed ID: 18155597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy evaluation of clonazepam for symptom remission in burning mouth syndrome: a meta-analysis.
    Cui Y; Xu H; Chen FM; Liu JL; Jiang L; Zhou Y; Chen QM
    Oral Dis; 2016 Sep; 22(6):503-11. PubMed ID: 26680638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective, randomized, double-blind, clinical evaluation of Aloe vera Barbadensis, applied in combination with a tongue protector to treat burning mouth syndrome.
    López-Jornet P; Camacho-Alonso F; Molino-Pagan D
    J Oral Pathol Med; 2013 Apr; 42(4):295-301. PubMed ID: 22957483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Burning mouth syndrome: a review and update.
    Sun A; Wu KM; Wang YP; Lin HP; Chen HM; Chiang CP
    J Oral Pathol Med; 2013 Oct; 42(9):649-55. PubMed ID: 23772971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.